MONOLISA ANTI-HBS EIA
FDA premarket approval P050048/S010 · decided 2025-04-18
Approval details
- PMA number
- P050048
- Supplement
- S010
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- MONOLISA ANTI-HBS EIA
- Generic name
- Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)
- Applicant
- Bio-Rad Laboratories
- Date received
- 2025-03-20
- Decision date
- 2025-04-18
- Days to decision
- 29 days
- Decision code
- OK30
- Product code
- LOM
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- Redmond, WA
- Statement
- a Validation to test the equivalency of a component with another so the original material can be replaced
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.